Specifically, the present invention provides a mutant Herpes Simplex Virus 2 comprising {HEAD ~ a modification} of {TAIL ~ the ICP10 gene} and the use of this mutant HSV 2 for the treatment of malignant diseases 
of
Specifically , the present invention provides a mutant Herpes Simplex Virus 2 comprising { HEAD ~ a modification } of { TAIL ~ the ICP10 gene } and the use of this mutant HSV 2 for the treatment of malignant diseases
OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD REL TAIL TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH